Lilly Endowment Sells $111.4M in Eli Lilly (LLY) Stock
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Lilly Endowment Sells $111.4M in Eli Lilly (LLY) Stock
Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-24 Significance: Low
Insider: LILLY ENDOWMENT INC Relationship: 10% Owner
Transaction: • Type: Sell • Shares: 105,326 • Avg. Price: $1,057.72 • Value: $111,406,141 • Owned After: 92,501,978
Key Insight: Despite the large dollar value, this sale by the company's largest shareholder represents a tiny fraction (0.011%) of shares outstanding and is considered a routine portfolio management transaction.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: ELI LILLY & Co (LLY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Lilly Endowment Inc., the largest institutional shareholder, executed a series of sales totaling $111.4 million, which is a routine transaction given the size of its holding and the company's market capitalization.
- Market Impact: The transaction is immaterial relative to the company's market cap and the insider's total holdings, suggesting a neutral market impact.
Company Information
| Field | Value |
|---|---|
| Company | ELI LILLY & Co |
| Ticker Symbol | LLY |
| CIK | 0000059478 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | LILLY ENDOWMENT INC |
| CIK | 0000316011 |
| Title/Position | null |
| Relationship | 10% Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-21 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 105,326 |
| Price Per Share | $1,057.72 (Weighted Avg.) |
| Total Value | $111,406,141.14 |
| Shares Owned After | 92,501,978 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $111,406,141.14 |
| % of Market Cap | 0.012% |
| Shares Transacted | 105,326 |
| % of Shares Outstanding | 0.011% |
| Post-Transaction Ownership | 92,501,978 shares (9.77% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company with a market capitalization of $917.64 billion, a transaction of $111.4 million is financially insignificant.
- Ownership Concentration: The sale represents a negligible reduction in the Endowment's substantial stake, which remains at approximately 9.77% of all outstanding shares post-transaction.
- Transaction Significance: The sale is less than 0.1% of both the company's market cap and its shares outstanding, falling well below the thresholds for moderate or high significance. This is likely part of a pre-planned diversification or liquidity strategy for the Endowment's philanthropic activities.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is too small relative to the company's size and the insider's total position to signal any change in outlook. It is a routine transaction for a large foundation.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is a small fraction of the stock's typical daily trading volume.
- Sentiment Indicator: Neutral. This type of sale from the Lilly Endowment is common and does not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing reports 17 separate sale transactions executed on the same day at weighted average prices. The data presented here is an aggregation of those transactions.
- Market Environment: The sale occurs while Eli Lilly is one of the largest companies in the world by market capitalization, making large dollar-value transactions by major holders appear routine.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
